Lexeo Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -538 | -530 | -510 | -501 |
EBITDA | 77,380 | -19,731 | -25,534 | -32,115 |
EBIT | 78,921 | -20,261 | -26,044 | -32,616 |
Net Income | -20,919 | -20,283 | -26,103 | -32,656 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -20,079 | -29,836 | -27,327 | -21,716 |
Cash | 63,000 | 40,996 | 35,480 | 28,913 |
Basic Shares | 536,453 | 60,980 | 43,573 | 33,113 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $654 |
Gross Profit | -2,079 | -2,001 | -1,843 | 654 |
EBITDA | -107,178 | -96,194 | -64,346 | -58,041 |
EBIT | -109,257 | -98,196 | -66,189 | -59,186 |
Net Income | -99,961 | -98,333 | -66,394 | -59,277 |
Net Change In Cash | 0 | 0 | 0 | 654 |
Free Cash Flow | -98,958 | -81,632 | -59,661 | -55,461 |
Cash | 63,000 | 35,014 | 121,466 | 77,335 |
Basic Shares | 536,453 | 31,787 | 26,646 | 25,169 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.27 |
2025-12-31 | -$0.27 |
2025-09-30 | -$0.33 |
2025-06-30 | -$0.60 |
